Protagenic Therapeutics Inc (NASDAQ:PTIX)
| 1.99 Delayed Data As of 11:43am ET |  -0.05 / -2.45%Today’s Change | 1.25 Today|||52-Week Range 3.44 | +24.37% Year-to-Date |
Latest PTIX News | Press Releases
No recent news for Protagenic Therapeutics Inc.
Today’s Trading
| Previous close | 2.04 |
| Today’s open | 1.99 |
| Day’s range | 1.99 - 1.99 |
| Volume | 117 |
| Average volume (3 months) | 8,568 |
| Market cap | -- |
Data as of 11:43am ET, 05/30/2023
Growth & Valuation
| Earnings growth (last year) | +32.91% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| CYCNCyclerion Therapeuti... | +0.23 | +5.64% |
| ATXIAvenue Therapeutics ... | -0.01 | -0.90% |
| --ValiRx PLC | -0.01 | -12.75% |
| ---- |
Data as of 3:58pm ET, 05/30/2023
Financials
| Last reporting date | April 7, 2022 |
| EPS forecast (this quarter) | -$0.20 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$3.6M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters New York, New York |
Forecasts
